Annual report pursuant to Section 13 and 15(d)

Note 9 - Income Taxes

v3.20.2
Note 9 - Income Taxes
12 Months Ended
Oct. 03, 2020
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

Note 9—Income Taxes

 

The Tax Cuts and Jobs Act of 2017 (the “New Tax Legislation”) was enacted on December 22, 2017, which significantly revised the U.S. corporate income tax code by, among other things, lowering federal corporate income tax rates, implementing a modified territorial tax system and imposing a repatriation tax, ("transition tax"), on deemed repatriated cumulative earnings of foreign subsidiaries which will be paid over eight years. In addition, new taxes were imposed related to foreign income, including a tax on global intangible low-taxed income (“GILTI”) as well as a limitation on the deduction for business interest expense (“Section 163(j)"). GILTI is the excess of the shareholder’s net controlled foreign corporations, ("CFC") net tested income over the net deemed tangible income.  The Section 163(j) limitation does not allow the amount of deductible interest to exceed the sum of the taxpayer's business interest income or 30% of the taxpayer’s adjusted taxable income. We have included in our calculation of our effective tax rate the estimated impact of GILTI and Section 163(j) which were effective for us beginning fiscal year 2019. We have elected to account for the tax on GILTI as a period cost and, therefore, do not record deferred taxes related to GILTI on our foreign subsidiaries.

 

The Coronavirus Aid, Relief, and Economic Security (“CARES Act”), which was enacted on March 27, 2020, provided temporary changes to income and non-income-based tax laws, including some provisions which were previously enacted under the New Tax Legislation. The CARES Act revised the U.S. corporate income tax code on a temporary basis by, among other things, eliminating the 80% of taxable income limitation on net operating loss (“NOL”) carryforwards, allowing NOL carrybacks, and increasing the Section 163(j) interest limitation deduction from 30% to 50% of adjusted taxable income. We have included the estimated impact of these provisions in our effective tax rate calculation.

 

The provision for (benefit from) income taxes consists of the following (in thousands):

 

   

Period ended

 
   

October 3, 2020

   

September 28, 2019

 

Current:

               

Federal

  $ 300     $ 732  

State

    50       (3 )

Foreign

    120       132  

Total current

  $ 470     $ 861  

Deferred:

               

Federal

  $ (3,200 )   $ (304 )

State

    (530 )     (80 )

Total deferred

    (3,730 )     (384 )

(Benefit from) provision for income taxes

  $ (3,260 )   $ 477  

 

For financial reporting purposes our (loss) income before provision for income taxes includes the following components (in thousands):

 

   

Period ended

 
   

October 3, 2020

   

September 28, 2019

 

United States, net of loss attributable to non-controlling interest

  $ (22,056 )   $ (2,321 )

Foreign

    8,219       11,040  
    $ (13,837 )   $ 8,719  

 

Our effective income tax rate on operations for fiscal year 2020 was 23.6% compared to a rate of 5.5% in the prior year. We generally benefit from having income in foreign jurisdictions that are either exempt from income taxes or have tax rates that are lower than those in the United States. As such, changes in the mix of U.S. taxable income compared to profits in tax-free or lower-tax jurisdictions can have a significant impact on our overall effective tax rate. Furthermore, we may be limited in our ability to deduct 50% of applicable foreign earnings under the GILTI income inclusion or to deduct U.S. interest expense based on lower U.S. taxable income due to the COVID-19 pandemic. In addition, the future impact of the CARES Act and New Tax Legislation may differ from historical amounts, possibly materially, due to, among other things, changes in interpretations and assumptions made regarding the CARES Act and New Tax Legislation, guidance that may be issued, and actions we may take as a result of the CARES Act and New Tax Legislation.

 

A reconciliation between the actual provision for income taxes and the provision for income taxes computed using the federal statutory income tax rate of 21.0% for fiscal years 2020 and 2019 is as follows (in thousands):

 

   

Period ended

 
   

October 3, 2020

   

September 28, 2019

 

Income tax expense at the statutory rate of 21.0%

  $ (2,906 )   $ 1,831  

State income tax benefits, net of federal income tax benefit

    (430 )     (82 )

Impact of foreign earnings in tax-free zone

    (1,604 )     (2,186 )

GILTI inclusion

    1,596       1,040  

Other permanent differences

    109       (140 )

Impact of state rate changes

    (144 )      

Other

    119       14  

(Benefit from) provision for income taxes

  $ (3,260 )   $ 477  

 

Significant components of our deferred tax assets and liabilities are as follows (in thousands):

 

   

October 3, 2020

   

September 28, 2019

 

Deferred tax assets:

               

State net operating loss carryforwards

  $ 2,490     $ 2,190  

Section 163(j) deduction carryforwards

    1,913       627  

Receivable allowances and reserves

    509       345  

Inventories and reserves

    4,176       2,960  

Accrued compensation and benefits

    2,213       1,789  
Operating lease liabilities     13,939        

Other

    517       466  

Gross deferred tax assets

  $ 25,757     $ 8,377  

Less valuation allowance — state net operating loss carryforwards

    (600 )     (516 )

Net deferred tax assets

  $ 25,157     $ 7,861  
                 

Deferred tax liabilities:

               

Depreciation

    (3,540 )     (4,611 )

Goodwill and intangibles

    (3,768 )     (3,183 )
Operating lease assets     (13,705 )      

Other

    (92 )     (72 )

Gross deferred tax liabilities

  $ (21,105 )   $ (7,866 )

Net deferred tax assets (liabilities)

  $ 4,052     $ (5 )

 

As of  October 3, 2020, we had state net operating losses ("NOLs") of approximately $52.6 million, with deferred tax assets of $2.5 million related to these state NOLs, and related valuation allowances against them of approximately $0.6 million. These state net loss carryforwards expire at various intervals from 2021 through 2040. Our deferred tax asset related to state net operating loss carryforwards is reduced by a valuation allowance to result in net deferred tax assets we consider more likely than not to be realized.

 

For both federal and state purposes, the ultimate realization of deferred tax assets depends upon the generation of future taxable income or tax planning strategies during the periods in which those temporary differences become deductible or when the carryforwards are available.

 

ASC 740, Income Taxes (“ASC 740”) requires that a position taken or expected to be taken in a tax return be recognized in the financial statements when it is more-likely-than-not (i.e., a likelihood of more than fifty percent) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. Accrued interest and penalties related to unrecognized tax benefits would also be recorded. We did not have any material unrecognized tax benefits as of  October 3, 2020, or September 28, 2019.

 

As of October 3, 2020, we are indefinitely reinvested in the cumulative undistributed earnings of and original investments in our foreign subsidiaries. Future remittances could be subject to additional foreign withholding taxes, U.S. state taxes, and certain tax impacts relating to foreign currency exchange effects. It is not practicable to estimate the amount of any unrecognized tax effects on these reinvested earnings and original investments in foreign subsidiaries.

 

We file income tax returns in the U.S. federal jurisdiction and various state, local and foreign jurisdictions. Tax years 2016, 2017, 2018, and 2019, according to statute and with few exceptions, remain open to examination by various federal, state, local, and foreign jurisdictions.